1. Home
  2. ASND vs HQY Comparison

ASND vs HQY Comparison

Compare ASND & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • HQY
  • Stock Information
  • Founded
  • ASND 2006
  • HQY 2002
  • Country
  • ASND Denmark
  • HQY United States
  • Employees
  • ASND N/A
  • HQY N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • HQY Business Services
  • Sector
  • ASND Health Care
  • HQY Consumer Discretionary
  • Exchange
  • ASND Nasdaq
  • HQY Nasdaq
  • Market Cap
  • ASND 9.9B
  • HQY 8.7B
  • IPO Year
  • ASND 2015
  • HQY 2014
  • Fundamental
  • Price
  • ASND $151.43
  • HQY $86.87
  • Analyst Decision
  • ASND Strong Buy
  • HQY Strong Buy
  • Analyst Count
  • ASND 14
  • HQY 13
  • Target Price
  • ASND $201.79
  • HQY $112.23
  • AVG Volume (30 Days)
  • ASND 409.7K
  • HQY 1.5M
  • Earning Date
  • ASND 05-01-2025
  • HQY 03-18-2025
  • Dividend Yield
  • ASND N/A
  • HQY N/A
  • EPS Growth
  • ASND N/A
  • HQY 70.31
  • EPS
  • ASND N/A
  • HQY 1.09
  • Revenue
  • ASND $376,478,932.00
  • HQY $1,199,774,000.00
  • Revenue This Year
  • ASND $61.43
  • HQY $9.35
  • Revenue Next Year
  • ASND $73.07
  • HQY $10.29
  • P/E Ratio
  • ASND N/A
  • HQY $79.86
  • Revenue Growth
  • ASND 36.34
  • HQY 20.03
  • 52 Week Low
  • ASND $111.09
  • HQY $65.01
  • 52 Week High
  • ASND $169.37
  • HQY $115.59
  • Technical
  • Relative Strength Index (RSI)
  • ASND 47.14
  • HQY 37.70
  • Support Level
  • ASND $143.81
  • HQY $85.00
  • Resistance Level
  • ASND $161.91
  • HQY $88.91
  • Average True Range (ATR)
  • ASND 6.32
  • HQY 3.59
  • MACD
  • ASND -1.66
  • HQY -0.08
  • Stochastic Oscillator
  • ASND 29.81
  • HQY 35.68

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Share on Social Networks: